A strategy for designing inhibitors of alpha-synuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders (Q33203491)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
A strategy for designing inhibitors of alpha-synuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders
scientific article

    Statements

    A strategy for designing inhibitors of alpha-synuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders (English)
    Katerina E Paleologou
    Abdulmawala M Abogrein

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit